Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

46 results about "Dna protein" patented technology

DNA is NOT a protein. DNA is made up from a chain of nucleotides. Proteins are built from a long chain of amino acids. Apart from the fact they're chaining together separate smaller molecules, they have very little in common. 3 nucleotides in DNA translate to one specific amino acid and there is some duplication.

Method of identifying active chromatin domains

The invention provides a method of mapping DNA-protein interactions within a genome by fixing living cells to cross-link DNA and proteins, lysing the cells, and isolating chromatin by immunoprecipitation. DNA is purified and a SAGE protocol is performed on the purified DNA to produce GMAT-tag sequences, which are compared to a genomic sequence of the living cells to map DNA-protein interactions. The invention further provides a method of identifying an active chromatin domain and a method of identifying aberrant chromatin acetylation, wherein chromatin immunoprecipitation is performed using an antibody recognizing acetylated histone protein.
Owner:GOVERNMENT OF THE US REPRESENTED BY THE SEC

Therapeutic nucleic acid-3' -conjugates

Methods are described for improvement of the serum half life of therapeutic nucleic acids by 3′ conjugation to useful target proteins, or other large molecules with useful function. In one embodiment, a 3′ A, C or G overhang is added to ds-DNA and the primary amines conjugated using biocompatible bifunctional linkers to proteins. The resulting nucleic acid-3′-conjugates are serum nuclease-resistant and retained in vivo for long periods without rapid kidney clearance. Further, the choice of conjugate imparts additional functionality to the nucleic acid-3-conjugate. For example, if the protein in the DNA-protein conjugate is the first component of the complement cascade (Clq or Clqrs) and the DNA aptamer has been developed against surface components of a target cell, it can be used to treat bacterial or parasitic infections and cancers. If the protein is serum albumin or another common (nonimmunogenic) blood protein and the aptamer is directed against a toxin or venom, the aptamer-protein conjugate can be used as an antidote that binds and neutralizes the toxin or venom. Similar DNA (aptamer)-nanotube, -enzyme, and -toxin conjugates could also be used to target and selectively kill bacteria, parasites, and cancer cells in vivo. If the protein is an Fc antibody fragment or C3b protein from the complement system and the aptamer is developed against a bacterial cell capsular material, other cell surface component or viral cell surface component, then the aptamer-3′-protein conjugate can aid in opsonization of the target cells or viruses by phagocytic leukocytes.
Owner:OTC BIOTECH

Ultrasonic crushing method for pig adipose tissue and application of ultrasonic crushing method

The invention belongs to the field of co-immunoprecipitation chromatin of chromatins and particularly relates to an ultrasonic crushing method for a pig adipose tissue and application of the ultrasonic crushing method. The method comprises the following steps: (1) carrying out ice formaldehyde cross-linking reaction on the pig adipose tissue; (2) stopping cross-linking reaction through glycine, and then carrying out centrifugation and ice-bath layering; (3) acquiring a cell deposition layer of the pig adipose tissue; (4) extracting a cell nucleus deposition layer; and (5) ultrasonically breaking chromatins, so as to obtain small fragments of a protein-nucleic acid compound. The ultrasonic crushing method has the beneficial effects that a low-temperature condition is maintained in the wholeexperiment operation, so that a natural structure of a protein is guaranteed to a great extent, and the DNA-protein compound adsorbed with a real antibody is obtained; the obtained small fragments ofthe protein-nucleic acid compound can be directly applied to subsequent ChIP, the concentration of obtained DNA is determined, and the combination condition between DNA and a target protein in a whole genome range is detected by virtue of high-flux sequencing; and DNA obtained through enrichment is used for establishing a bank, is subjected to second-generation sequencing and is applied to the bioinformatics analysis of DNA of the pig adipose tissue.
Owner:WUHAN IGENEBOOK BIOTECH CO LTD

DNase high-throughput sequencing detection signal processing method of DNA protein binding sites

The invention discloses a DNase high-throughput sequencing detection signal processing method of DNA protein binding sites. The method comprises the following steps: basic information of gene and DNase-Seq high-throughput sequencing detection data and ChIP-Seq high-throughput sequencing monitoring data of DNA protein binding sites are obtained; quality evaluation of the DNase-Seq high-throughput sequencing detection data is carried out, and credible sequencing data are screened out; only credible sequencing datum for directly reflecting sequencing initial position of protein binding sites is retained; a DNase-Seq detection sample data set is obtained; normalization processing is carried out on the DNase-Seq detection sample data set; the DNase-Seq detection sample data set is subdivided; and vertical summation of data in two subsets is carried out respectively from two directions of the front and back so as to finish operations. According to the invention, recognition precision and recognition resolution of the DNA protein binding sites are greatly raised.
Owner:HARBIN ENG UNIV

Whole genome interaction library and construction method thereof

The invention provides a whole genome interaction library and a construction method thereof. The construction method comprises the following steps of step S1, using a primer sequence to link ends, generated by enzyme digestion, of a DNA-protein cross-linking complex to form a cyclic complex; step S2, conducting decrosslinking on the cyclic complex to obtain cyclic DNA; step S3, conducting fragmented library construction on the cyclic DNA to obtain the whole genome interaction library. The method uses a section of exogenous known DNA sequence to link the ends of enzyme-digested product fragments, so that the DNA-protein cross-linking complex forms the cyclic complex, then proteins in the cyclic complex are removed by crosslinking to obtain the cyclic DNA, the exogenous known DNA sequence carried by the cyclic DNA is used for fragmented library construction to obtain the whole genome interaction library for whole genome interaction research, and a whole genome interaction research methodwhich is simple and has wide operability is provided.
Owner:CHINA NAT RICE RES INST

Method for extracting nucleic acid from bee pollen and purifying

The invention belongs to the technical field of biochemistry, and provides a method for extracting nucleic acid from bee pollen and purifying. The specific method is as follows: freezing screened, purified and dried bee pollen, and ultrafine grinding until the particle size achieves 20-60 meshes, adding a 0.14mol/L sodium chloride solution with weight ratio of 1: (8-10), homogenating, separating organelle through differential centrifugation, and ultrasonically treating for 30-40 minutes at 20-30 KHz, cracking to obtain DNA-proteins, then adding a 1mol/L sodium chloride solution with weight ratio of 1: (6-8), homogenating, ultrasonically treating for 30-40 minutes at 20-30 KHz, cracking to obtain RNA-nucleoproteins, adding a proper amount of sodium dodecyl sulfate to separate the proteins from nucleoproteins, adding concentrated potassium acetate, precipitating a sodium dodecyl sulfate-protein complex, transforming spare sodium dodecyl sulfate as sylvite with small solubility and simultaneously precipitating, repeatedly extracting, obtaining a nucleic acid pure solution through ultracentrifugation or ion-exchange column chromatography, and performing vacuum freezing and drying on the nucleic acid pure solution to obtain the pure nucleic acid substance.
Owner:大兴安岭绿源蜂业有限公司

Compound-type biological disinfector and preparation method thereof

InactiveCN108566958APowerful killStrong bactericidal specificityBiocideDisinfectantsDiseaseSide effect
The invention relates to a compound-type biological disinfector and a preparation method thereof, and belongs to the field of biotechnologies. The compound-type biological disinfector is capable of loading pharmaceutical active ingredient factors in multiple traditional Chinese medicinal materials on chitosan, compounding through subacidity electrolytic water, releasing to a space in a constant speed, performing a special reaction with an amino, and breaking activity of bacteria, penetrating a cytomembrane, breaking an organic matter chain structure, causing the generation of a DNA protein andthe synthesis retardation of a substance, strongly killing microorganisms, such as pathogenic bacteria and viruses, contained in the air, thereby effectively preventing and treating various airborneinfection diseases of influenza, respiratory tract infection, pneumonia and the like. Compared with the prior art, the compound-type biological disinfector is low in price, good in sterilizing effect,rapid in efficacy speed, extremely strong in killing capacity to the bacteria and the viruses, non-irritant, odorless, tasteless, low in toxic and side effects, non-irritant to skin and mucosa without a residual harmful substance, and has the important significance to improve the environment and guarantee the environmental sanitation.
Owner:FOSHAN WANYANG BIOLOGICAL TECH CO LTD

Method and kit for extracting genomic DNA from whole blood

InactiveCN109609493ASolve Z-value anomaliesSolve the abnormal Z value, a large number of fragments are missingDNA preparationBlood Collection TubeCross-link
The present invention provides a method and kit for extracting genomic DNA from whole blood. The method comprises: separating white blood cells from whole blood; breaking white blood cells to obtain broken white blood cells; and performing cell lysis and DNA-protein de-crosslinking on the broken white blood cells to obtain genomic DNA. By creatively breaking white blood cells and by breaking DNA and protein into small fragments, DNA-protein cross-linking sites are exposed to facilitate splitting and de-crosslinking, so that the extracted DNA is relatively more comprehensive and complete. The obtained DNA fragments satisfy the needs of subsequent database construction, and do not need to be broken again. Therefore, the method and kit specifically solves the problem that white blood cell fixation by preservation solution of a free DNA blood collection tube causes chromosome Z value abnormality, a large number of fragment deletions and repetitions.
Owner:BEIJING USCI MEDICAL LAB CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products